Analyst Ratings for CIGNA (CI)
CI Rating Summary
CI Price Target Summary
- Highest: $400.00 (UBS)
- Lowest: $297.00 (Nephron)
- Average: $342.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$342.14 (+14.8%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Avg. $ Target:
$342.14 (+14.8%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Barclays | Andrew Mok | Downgrade | Equalweight (Overweight) |
304.00 (310.00) |
286.24 (298.00) |
4.11% | Details |
| 5/20/2026 | Deutsche Bank | George Hill | Downgrade | Hold (Buy) |
302.00 (303.00) |
291.28 (298.00) |
2.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
